In June 2021, during the Gavi COVAX AMC Summit “One World Protected”, Mexico announced a donation of US$ 250,000 for the Gavi COVAX AMC as a first contribution to Gavi.

“We need to see ourselves as a single community, rather than as individual countries with our own national interests. What is at play is seeing how far we can go in achieving common goals through multilateral mechanisms such as COVAX,” said the Secretary of Foreign Affairs, Marcelo Ebrard.

Mexico’s partnership with Gavi supports the objectives of the development policy of the Mexican Government to fight global pandemics and improve maternal and infant health by increasing access to vaccination and health systems in the world’s least developed countries.

Proceeds to Gavi from donor contributions & pledges (2021-2025) as of 30 June 2023

Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.

Contributions and pledges over time (US$ Millions)

Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data

Notes:
Direct Contributions (including Matching Fund)

Received contributions: non-US$ contributions for 2000–2022 and Q1-Q2 2023 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014–2022 and Q1-Q2 2023 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.

Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2023 and for years 2024 and beyond are expressed in US$ equivalents using the applicable forecast rates from Bloomberg as at 30 June 2023 or using the rates applicable to any hedge agreement in place.

Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2023 and for years 2024 and beyond are expressed in US$ equivalents using the spot rates from Refinitiv as at 30 June 2023 or using the rates applicable to any hedge agreement in place.

IFFIm contributions

Received contributions: non-US$ contributions for 2000-2022 and Q1-Q2 2023 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)

Future contributions: non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2023 and for years 2024 and beyond are expressed in US$ equivalents using the applicable forecast rates from Bloomberg as at 30 June 2023 or using the rates applicable to any hedge agreement in place.

  • For signed contribution agreements: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
  • For contribution agreements not yet signed: contributions are expressed in US$ equivalents using the applicable spot rates from Refinitiv as at 30 June 2023

Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.

While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due by the donor in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund. Since 29 June 2021, there is no longer any reduction applied, as all countries from the reference portfolio have cleared their arrears with the IMF.

All donors

Subscribe to our newsletter